| Autophagy in major human diseases DJ Klionsky, G Petroni, RK Amaravadi, EH Baehrecke, A Ballabio, P Boya, ... The EMBO journal 40 (19), e108863, 2021 | 427 | 2021 |
| Detection of immunogenic cell death and its relevance for cancer therapy J Fucikova, O Kepp, L Kasikova, G Petroni, T Yamazaki, P Liu, L Zhao, ... Cell death & disease 11 (11), 1013, 2020 | 350 | 2020 |
| Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy T Yamazaki, A Kirchmair, AI Sato, A Buqué, M Rybstein, G Petroni, N Bloy, ... Nature immunology 21 (10), 1160-1171, 2020 | 185 | 2020 |
| Immunomodulation by targeted anticancer agents G Petroni, A Buqué, L Zitvogel, G Kroemer, L Galluzzi Cancer cell 39 (3), 310-345, 2021 | 112 | 2021 |
| Immunomodulation by anticancer cell cycle inhibitors G Petroni, SC Formenti, S Chen-Kiang, L Galluzzi Nature Reviews Immunology 20 (11), 669-679, 2020 | 93 | 2020 |
| Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients ME Rodriguez-Ruiz, A Buqué, M Hensler, J Chen, N Bloy, G Petroni, ... Oncoimmunology 8 (11), e1655964, 2019 | 92 | 2019 |
| Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab A Matucci, S Pratesi, G Petroni, F Nencini, G Virgili, M Milla, E Maggi, ... Clinical & Experimental Allergy 43 (6), 659-664, 2013 | 92 | 2013 |
| Noncanonical cell fate regulation by Bcl-2 proteins SJF Chong, S Marchi, G Petroni, G Kroemer, L Galluzzi, S Pervaiz Trends in Cell Biology 30 (7), 537-555, 2020 | 71 | 2020 |
| Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab A Vultaggio, A Matucci, F Nencini, S Pratesi, G Petroni, D Cammelli, ... International archives of allergy and immunology 159 (3), 321-326, 2012 | 63 | 2012 |
| The combined activation of KCa3. 1 and inhibition of Kv11. 1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells S Pillozzi, M D'Amico, G Bartoli, L Gasparoli, G Petroni, O Crociani, ... British journal of cancer 118 (2), 200-212, 2018 | 60 | 2018 |
| Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer G Petroni, LC Cantley, L Santambrogio, SC Formenti, L Galluzzi Nature Reviews Clinical Oncology 19 (2), 114-131, 2022 | 54 | 2022 |
| The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression A Becchetti, S Crescioli, F Zanieri, G Petroni, R Mercatelli, S Coppola, ... Science signaling 10 (473), eaaf3236, 2017 | 49 | 2017 |
| Ion channel conformations regulate integrin-dependent signaling A Becchetti, G Petroni, A Arcangeli Trends in cell biology 29 (4), 298-307, 2019 | 46 | 2019 |
| Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment G Petroni, A Buqué, LM Coussens, L Galluzzi Nature reviews Drug discovery 21 (6), 440-462, 2022 | 43 | 2022 |
| Manifestations of antidrug antibodies response: hypersensitivity and infusion reactions A Vultaggio, F Nencini, S Pratesi, G Petroni, E Maggi, A Matucci Journal of Interferon & Cytokine Research 34 (12), 946-952, 2014 | 42 | 2014 |
| Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer G Petroni, A Buqué, T Yamazaki, N Bloy, MD Liberto, S Chen-Kiang, ... Clinical Cancer Research 27 (7), 1855-1863, 2021 | 38 | 2021 |
| Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K G Petroni, G Bagni, J Iorio, C Duranti, T Lottini, M Stefanini, G Kragol, ... Cell death & disease 11 (3), 161, 2020 | 29 | 2020 |
| Assays and strategies for immunogenicity assessment of biological agents F Nencini, S Pratesi, G Petroni, A Matucci, E Maggi, A Vultaggio Drug Development Research 75, S4-S6, 2014 | 28 | 2014 |
| Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions A Vultaggio, G Petroni, S Pratesi, F Nencini, D Cammelli, M Milla, ... Clinical & Experimental Immunology 186 (3), 364-372, 2016 | 27 | 2016 |
| New gold carbene complexes as candidate anticancer agents A Pratesi, D Cirri, MD Đurović, S Pillozzi, G Petroni, ŽD Bugarčić, ... Biometals 29, 905-911, 2016 | 26 | 2016 |
